Literature DB >> 26024112

Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.

William S Fischer1, Michael Wall2, Michael P McDermott3, Mark J Kupersmith4, Steven E Feldon1.   

Abstract

PURPOSE: To describe the methods used by the Photographic Reading Center (PRC) of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) and to report baseline assessments of papilledema severity in participants.
METHODS: Stereoscopic digital images centered on the optic disc and the macula were collected using certified personnel and photographic equipment. Certification of the camera system included standardization and calibration using a model eye. Lay readers assessed disc photos of all eyes using the Frisén grade and performed quantitative measurements of papilledema. Frisén grades by PRC were compared with site investigator clinical grades. Spearman rank correlations were used to quantify associations among disc features and selected clinical variables.
RESULTS: Frisén grades according to the PRC and site investigator's grades, matched exactly in 48% of the study eyes and 42% of the fellow eyes and within one grade in 94% of the study eyes and 92% of the fellow eyes. Frisén grade was strongly correlated (r > 0.65, P < 0.0001) with quantitative measures of disc area. Cerebrospinal fluid pressure was weakly associated with Frisén grade and disc area determinations (r ≤ 0.31). Neither Frisén grade nor any fundus feature was associated with perimetric mean deviation.
CONCLUSIONS: In a prospective clinical trial, lay readers agreed reasonably well with physicians in assessing Frisén grade. Standardization of camera systems enhanced consistency of photographic quality across study sites. Images were affected more by sensors with poor dynamic range than by poor resolution. Frisén grade is highly correlated with quantitative assessment of disc area. (ClinicalTrials.gov number, NCT01003639.).

Entities:  

Mesh:

Year:  2015        PMID: 26024112      PMCID: PMC4453296          DOI: 10.1167/iovs.15-16465

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

Review 1.  Pseudotumor cerebri.

Authors:  Deborah I Friedman
Journal:  Neurol Clin       Date:  2004-02       Impact factor: 3.806

2.  Quantitative evaluation of papilledema from stereoscopic color fundus photographs.

Authors:  Li Tang; Randy H Kardon; Jui-Kai Wang; Mona K Garvin; Kyungmoo Lee; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-03       Impact factor: 4.799

3.  Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography.

Authors:  Jui-Kai Wang; Randy H Kardon; Mark J Kupersmith; Mona K Garvin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-29       Impact factor: 4.799

4.  Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

Authors:  Michael Wall; Michael P McDermott; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Mark J Kupersmith
Journal:  JAMA       Date:  2014 Apr 23-30       Impact factor: 56.272

5.  The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.

Authors:  Michael Wall; Mark J Kupersmith; Karl D Kieburtz; James J Corbett; Steven E Feldon; Deborah I Friedman; David M Katz; John L Keltner; Eleanor B Schron; Michael P McDermott
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

6.  Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability.

Authors:  Peggy Auinger; Mary Durbin; Steven Feldon; Mona Garvin; Randy Kardon; John Keltner; Mark Kupersmith; Patrick Sibony; Kim Plumb; Jui-Kai Wang; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-04       Impact factor: 4.799

7.  Retinal vessel diameter assessment in papilledema by semi-automated analysis of SLO images: feasibility and reliability.

Authors:  Heather E Moss; Gillian Treadwell; Justin Wanek; Sherryl DeLeon; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-03       Impact factor: 4.799

8.  Automated analysis of optic nerve images for detection and staging of papilledema.

Authors:  Sebastian Echegaray; Gilberto Zamora; Honggang Yu; Wenbin Luo; Peter Soliz; Randy Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-27       Impact factor: 4.799

9.  Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2).

Authors:  Ronald P Danis; Amitha Domalpally; Emily Y Chew; Traci E Clemons; Jane Armstrong; John Paul SanGiovanni; Frederick L Ferris
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-08       Impact factor: 4.799

10.  Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.

Authors:  Peggy Auinger; Mary Durbin; Steven Feldon; Mona Garvin; Randy Kardon; John Keltner; Mark J Kupersmith; Patrick Sibony; Kim Plumb; Jui-Kai Wang; John S Werner
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-04       Impact factor: 4.799

View more
  14 in total

1.  The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.

Authors:  Mark J Kupersmith; Patrick A Sibony; Steven E Feldon; Jui-Kai Wang; Mona Garvin; Randy Kardon
Journal:  Am J Ophthalmol       Date:  2016-12-28       Impact factor: 5.258

Review 2.  Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension.

Authors:  Sarah R Ahmad; Heather E Moss
Journal:  Semin Neurol       Date:  2019-12-17       Impact factor: 3.420

3.  Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.

Authors: 
Journal:  Ophthalmology       Date:  2015-07-18       Impact factor: 12.079

4.  Linear interactions between intraocular, intracranial pressure, and retinal vascular pulse amplitude in the fourier domain.

Authors:  Anmar Abdul-Rahman; William Morgan; Ying Jo Khoo; Christopher Lind; Allan Kermode; William Carroll; Dao-Yi Yu
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

5.  Retinal and Choroidal Folds in Papilledema.

Authors:  Patrick A Sibony; Mark J Kupersmith; Steven E Feldon; Jui-Kai Wang; Mona Garvin
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

6.  The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.

Authors:  Catherine R Sheils; William S Fischer; Rachel A Hollar; Lisa M Blanchard; Steven E Feldon
Journal:  Am J Ophthalmol       Date:  2018-08-04       Impact factor: 5.258

7.  Retinal vessel diameter changes after 6 months of treatment in the Idiopathic Intracranial Hypertension Treatment Trial.

Authors:  Heather E Moss; Rachel A Hollar; William S Fischer; Steven E Feldon
Journal:  Br J Ophthalmol       Date:  2020-01-16       Impact factor: 4.638

8.  Accuracy of a Deep Learning System for Classification of Papilledema Severity on Ocular Fundus Photographs.

Authors:  Caroline Vasseneix; Raymond P Najjar; Xinxing Xu; Zhiqun Tang; Jing Liang Loo; Shweta Singhal; Sharon Tow; Leonard Milea; Daniel Shu Wei Ting; Yong Liu; Tien Y Wong; Nancy J Newman; Valerie Biousse; Dan Milea
Journal:  Neurology       Date:  2021-05-19       Impact factor: 9.910

9.  Retinal Vessel Diameters Change Within 1 Hour of Intracranial Pressure Lowering.

Authors:  Heather E Moss; Gautam Vangipuram; Zainab Shirazi; Mahnaz Shahidi
Journal:  Transl Vis Sci Technol       Date:  2018-03-19       Impact factor: 3.283

10.  A new novel method for assessing intracranial pressure using non-invasive fundus images: a pilot study.

Authors:  Mikkel Schou Andersen; Christian Bonde Pedersen; Frantz Rom Poulsen
Journal:  Sci Rep       Date:  2020-08-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.